Biogen Inc.
BIIB
$185.43
$1.410.77%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -48.90M | 466.50M | 634.80M | 240.50M | 266.70M |
| Total Depreciation and Amortization | 200.20M | 202.20M | 194.30M | 183.20M | 184.00M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 469.30M | 429.60M | 121.40M | 169.10M | 281.90M |
| Change in Net Operating Assets | -108.70M | 174.20M | -789.60M | -333.50M | 28.30M |
| Cash from Operations | 511.90M | 1.27B | 160.90M | 259.30M | 760.90M |
| Capital Expenditure | -43.90M | -46.20M | -26.60M | -37.10M | -39.30M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | 0.00 |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -1.19B | 11.10M | -30.40M | -10.20M | 20.70M |
| Cash from Investing | -1.23B | -35.10M | -57.00M | -47.30M | -18.60M |
| Total Debt Issued | 0.00 | -300.00K | 1.73B | -- | -- |
| Total Debt Repaid | -280.00M | 0.00 | -1.75B | -- | 0.00 |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 143.00M | -129.90M | 4.90M | -23.00M | 7.90M |
| Cash from Financing | -137.00M | -130.20M | -11.70M | -23.00M | 7.90M |
| Foreign Exchange rate Adjustments | 2.50M | -3.20M | 68.30M | 34.30M | -74.40M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -854.30M | 1.10B | 160.50M | 223.30M | 675.80M |